Newron to Present Data and Updates on its Clinical Program Evaluating Evenamide as an Add-on Treatment for Schizophrenia at the 2025 World Congress of Biological Psychiatry (WCBP)
You are currently viewing a placeholder content from Elfsight. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
